Long noncoding RNA RMRP ameliorates doxorubicin-induced apoptosis by interacting with PFN1 in a P53-Dependent manner

Doxorubicin (DOX) often causes acute or chronic cardiotoxicity during its application. LncRNA RMRP has been reported to be associated with several biological processes, such as cartilage-hair hypoplasia, but the relationship between RMRP and DOX-induced cardiotoxicity and chronic heart failure remai...

Full description

Bibliographic Details
Main Authors: Juexing Li, Lei Zhou, Yuanliang Jiang, Hailan Gao, Tuersuntuoheti Maierhaba, Hui Gong
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Molecular and Cellular Probes
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0890850823000464
_version_ 1827596477241753600
author Juexing Li
Lei Zhou
Yuanliang Jiang
Hailan Gao
Tuersuntuoheti Maierhaba
Hui Gong
author_facet Juexing Li
Lei Zhou
Yuanliang Jiang
Hailan Gao
Tuersuntuoheti Maierhaba
Hui Gong
author_sort Juexing Li
collection DOAJ
description Doxorubicin (DOX) often causes acute or chronic cardiotoxicity during its application. LncRNA RMRP has been reported to be associated with several biological processes, such as cartilage-hair hypoplasia, but the relationship between RMRP and DOX-induced cardiotoxicity and chronic heart failure remains obscure. To test this hypothesis, GSE124401 and GSE149870 were processed for bioinformatics, and differentially expressed RMRP was then verified in the peripheral blood of 21 patients with heart failure compared with 7 controls. For in vitro validation, we used AC16 and HEK-293T cells. qPCR was used to detect the mRNA expression levels. The degree of apoptosis was detected by Western blot and TUNEL staining. Furthermore, the interaction between RMRP and PFN1 mRNA was verified by dual-luciferase reporter assays. In bioinformatics, RMRP showed significant downregulation, which was verified in clinical samples (p < 0.001) and DOX-treated AC16 models (p < 0.0001). Next, overexpression of RMRP could significantly alleviate DOX-induced apoptosis, and a potential downstream molecule of RMRP, PFN1, was also negatively associated with this change. RESCUE experiments further confirmed that PFN1 could be regulated by RMRP at both the RNA and protein levels, serving as a downstream mediator of RMRP's cardioprotective effects. This interaction was then confirmed to be a direct combination (p < 0.0001). Finally, we found that overexpression of RMRP could inhibit the expression of p53 and its phosphorylation level by suppressing PFN1. In summary, RMRP could exert cardioprotective effects via the PFN1/p53 axis, holding great promise for serving as a therapeutic target and potential biomarker.
first_indexed 2024-03-09T03:11:07Z
format Article
id doaj.art-9232c2e59a3d4e3ca73350d28abecd05
institution Directory Open Access Journal
issn 0890-8508
language English
last_indexed 2024-03-09T03:11:07Z
publishDate 2023-12-01
publisher Elsevier
record_format Article
series Molecular and Cellular Probes
spelling doaj.art-9232c2e59a3d4e3ca73350d28abecd052023-12-04T05:21:21ZengElsevierMolecular and Cellular Probes0890-85082023-12-0172101937Long noncoding RNA RMRP ameliorates doxorubicin-induced apoptosis by interacting with PFN1 in a P53-Dependent mannerJuexing Li0Lei Zhou1Yuanliang Jiang2Hailan Gao3Tuersuntuoheti Maierhaba4Hui Gong5Department of Cardiology, Jinshan Hospital of Fudan University, Shanghai, 201508, China; Department of Internal Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, ChinaDepartment of Cardiology, Jinshan Hospital of Fudan University, Shanghai, 201508, China; Department of Internal Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, ChinaDepartment of Psychiatry, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Cardiology, Jinshan Hospital of Fudan University, Shanghai, 201508, China; Department of Internal Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, ChinaDepartment of Cardiology, Jinshan Hospital of Fudan University, Shanghai, 201508, China; Department of Internal Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, ChinaDepartment of Cardiology, Jinshan Hospital of Fudan University, Shanghai, 201508, China; Department of Internal Medicine, Shanghai Medical College, Fudan University, Shanghai, 200032, China; Corresponding author. Department of Cardiology, Jinshan Hospital of Fudan University, 1508 Longhang Road, Jinshan District, Shanghai, 201508, China.Doxorubicin (DOX) often causes acute or chronic cardiotoxicity during its application. LncRNA RMRP has been reported to be associated with several biological processes, such as cartilage-hair hypoplasia, but the relationship between RMRP and DOX-induced cardiotoxicity and chronic heart failure remains obscure. To test this hypothesis, GSE124401 and GSE149870 were processed for bioinformatics, and differentially expressed RMRP was then verified in the peripheral blood of 21 patients with heart failure compared with 7 controls. For in vitro validation, we used AC16 and HEK-293T cells. qPCR was used to detect the mRNA expression levels. The degree of apoptosis was detected by Western blot and TUNEL staining. Furthermore, the interaction between RMRP and PFN1 mRNA was verified by dual-luciferase reporter assays. In bioinformatics, RMRP showed significant downregulation, which was verified in clinical samples (p < 0.001) and DOX-treated AC16 models (p < 0.0001). Next, overexpression of RMRP could significantly alleviate DOX-induced apoptosis, and a potential downstream molecule of RMRP, PFN1, was also negatively associated with this change. RESCUE experiments further confirmed that PFN1 could be regulated by RMRP at both the RNA and protein levels, serving as a downstream mediator of RMRP's cardioprotective effects. This interaction was then confirmed to be a direct combination (p < 0.0001). Finally, we found that overexpression of RMRP could inhibit the expression of p53 and its phosphorylation level by suppressing PFN1. In summary, RMRP could exert cardioprotective effects via the PFN1/p53 axis, holding great promise for serving as a therapeutic target and potential biomarker.http://www.sciencedirect.com/science/article/pii/S0890850823000464ApoptosisDoxorubicinHeart failureLncRNA RMRPPFN1
spellingShingle Juexing Li
Lei Zhou
Yuanliang Jiang
Hailan Gao
Tuersuntuoheti Maierhaba
Hui Gong
Long noncoding RNA RMRP ameliorates doxorubicin-induced apoptosis by interacting with PFN1 in a P53-Dependent manner
Molecular and Cellular Probes
Apoptosis
Doxorubicin
Heart failure
LncRNA RMRP
PFN1
title Long noncoding RNA RMRP ameliorates doxorubicin-induced apoptosis by interacting with PFN1 in a P53-Dependent manner
title_full Long noncoding RNA RMRP ameliorates doxorubicin-induced apoptosis by interacting with PFN1 in a P53-Dependent manner
title_fullStr Long noncoding RNA RMRP ameliorates doxorubicin-induced apoptosis by interacting with PFN1 in a P53-Dependent manner
title_full_unstemmed Long noncoding RNA RMRP ameliorates doxorubicin-induced apoptosis by interacting with PFN1 in a P53-Dependent manner
title_short Long noncoding RNA RMRP ameliorates doxorubicin-induced apoptosis by interacting with PFN1 in a P53-Dependent manner
title_sort long noncoding rna rmrp ameliorates doxorubicin induced apoptosis by interacting with pfn1 in a p53 dependent manner
topic Apoptosis
Doxorubicin
Heart failure
LncRNA RMRP
PFN1
url http://www.sciencedirect.com/science/article/pii/S0890850823000464
work_keys_str_mv AT juexingli longnoncodingrnarmrpamelioratesdoxorubicininducedapoptosisbyinteractingwithpfn1inap53dependentmanner
AT leizhou longnoncodingrnarmrpamelioratesdoxorubicininducedapoptosisbyinteractingwithpfn1inap53dependentmanner
AT yuanliangjiang longnoncodingrnarmrpamelioratesdoxorubicininducedapoptosisbyinteractingwithpfn1inap53dependentmanner
AT hailangao longnoncodingrnarmrpamelioratesdoxorubicininducedapoptosisbyinteractingwithpfn1inap53dependentmanner
AT tuersuntuohetimaierhaba longnoncodingrnarmrpamelioratesdoxorubicininducedapoptosisbyinteractingwithpfn1inap53dependentmanner
AT huigong longnoncodingrnarmrpamelioratesdoxorubicininducedapoptosisbyinteractingwithpfn1inap53dependentmanner